Birgit Bollbuck
Impact in
- Cell Biology top 5%
- Microtubule and mitosis dynamics
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
Papers in
-
- Eicosanoids and Hypertension Pharmacology 4
-
- Organic Chemistry Synthesis Methods 4
- Synthesis and biological activity 4
- Asymmetric Synthesis and Catalysis 2
- Advanced Synthetic Organic Chemistry 2
- Co-authors
- Rick Gussio (2 shared papers)Daniel W. Zaharevitz (2 shared papers)K. C. Nicolaou (1 shared paper)George Poy (1 shared paper)Paraskevi Giannakakou (1 shared paper)Dan L. Sackett (1 shared paper)Kenneth H. Downing (1 shared paper)Eva Nogales (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Tetrahedron (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Scientific Reports (1 paper)PLoS ONE (1 paper)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Birgit Bollbuck
16 papers receiving 929 citations
Peers
Comparison fields: 5 of 67
- Cell Biology 240
- Oncology 255
- Organic Chemistry 268
- Cancer Research 74
- Computational Theory and Mathematics 77
Countries citing papers authored by Birgit Bollbuck
This map shows the geographic impact of Birgit Bollbuck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Bollbuck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Bollbuck more than expected).
Fields of papers citing papers by Birgit Bollbuck
This network shows the impact of papers produced by Birgit Bollbuck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Bollbuck. The network helps show where Birgit Bollbuck may publish in the future.
Co-authors
The 25 scholars most cited alongside Birgit Bollbuck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 426 | |
| 2 | 2000 | 132 | |
| 3 | 2005 | 128 | |
| 4 | 2012 | 104 | |
| 5 | 2000 | 48 | |
| 6 | 2005 | 30 | |
| 7 | 2017 | 27 | |
| 8 | 2021 | 24 | |
| 9 | 2012 | 21 | |
| 10 | 1996 | 19 | |
| 11 | 2016 | 18 | |
| 12 | 2006 | 8 | |
| 13 | 1999 | 5 | |
| 14 | 1999 | 5 | |
| 15 | 2023 | 5 | |
| 16 | Discovery of LYS006, a Potent and Highly Selective Inhibitor of Leukotriene A4 Hydrolase | 2021 | 1 |
About Birgit Bollbuck
Birgit Bollbuck is a scholar working on Biochemistry, Organic Chemistry, Pharmacology, Computational Theory and Mathematics and Oncology, having authored 16 papers that have together received 1k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (4 papers), Organic Chemistry Synthesis Methods (4 papers), Synthesis and biological activity (4 papers), Inflammatory mediators and NSAID effects (3 papers), Sphingolipid Metabolism and Signaling (3 papers), Computational Drug Discovery Methods (3 papers), Asymmetric Synthesis and Catalysis (2 papers) and Advanced Synthetic Organic Chemistry (2 papers). The work is most often cited by research in Cell Biology (240 citations), Oncology (255 citations), Organic Chemistry (268 citations), Cancer Research (74 citations) and Computational Theory and Mathematics (77 citations). Birgit Bollbuck has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Rick Gussio, Daniel W. Zaharevitz, K. C. Nicolaou, George Poy, Paraskevi Giannakakou, Dan L. Sackett, Kenneth H. Downing, Eva Nogales, Tito Fojo and René Hersperger. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron, Bioorganic & Medicinal Chemistry Letters, Scientific Reports and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.